Ireland's ICON Q1 results beat estimates on commercial momentum
Ireland's ICON Q1 results beat estimates on commercial momentum
Overview
Ireland clinical research firm's Q1 revenue up 0.9% yr/yr, beating analyst expectations
Q1 adjusted EPS beat analyst expectations
Company reaffirmed 2026 full-year guidance
Outlook
ICON reaffirms 2026 revenue guidance of $7.85 bln to $8.15 bln
Company maintains 2026 adjusted diluted EPS outlook of $10.00 to $11.00
ICON expects incremental progress through 2026, citing strong commercial momentum
Result Drivers
COMMERCIAL MOMENTUM - Co said strong net bookings and a book-to-bill ratio of 1.42 were driven by robust gross award activity and low cancellations
PARTNERSHIPS - Improved win rates supported by partnerships added in H2 2025 and two new partnerships in the quarter, per CEO Barry Balfe
BUSINESS MIX - Co said Q1 financial performance was impacted, as expected, by business mix
Company press release: ID:nBw7BNwsa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Revenue | Beat | $2.03 bln | $1.99 bln (14 Analysts) |
Q1 Adjusted EPS | Beat | $2.50 | $2.42 (12 Analysts) |
Q1 Net Income |
| $104.75 mln |
|
Q1 Adjusted EBITDA | Beat | $317.73 mln | $314.21 mln (14 Analysts) |
Q1 Operating Income | Miss | $173.73 mln | $265.47 mln (11 Analysts) |
Q1 Pretax Profit | Miss | $127.56 mln | $224.28 mln (10 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy"
Wall Street's median 12-month price target for ICON PLC is $160.00, about 13.7% above its June 22 closing price of $140.73
The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 9 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Icon
See all newsIreland's ICON Q1 results beat estimates on commercial momentum
Brief: ICON Schedules First Quarter 2026 Earnings Conference Call
Icon Plc Reports Results For The Quarter Ended December 31: Earnings Summary
Brief: Icon Expands Us Early Phase Research Capabilities With New Clinic And Outpatient Centres
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy